Angiotensin receptor neprilysin inhibitors and renal outcomes in patients with heart failure: a systematic review and meta-analysis.
This systematic review and meta-analysis examined renal outcomes with angiotensin receptor neprilysin inhibitors (ARNi) versus renin-angiotensin-aldosterone system inhibitors (RAASi) alone in patients with heart…
Why it matters
Renal effects are an important consideration when selecting and monitoring heart failure therapy. These pooled trial findings suggest ARNi may be associated with fewer adverse renal outcomes than RAASi alone, while the…